BioSpace News Archive

Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., today stated that the country does have the know-how and means to provide, “swift, safe, non-invasive and accurate testing methodology to help send our kids back to school.”

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced the pricing of a $5.6 million offering, which consisted of an underwritten public offering of units and a private placement of units for gross proceeds of approximately $5.6 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the company. The public offering is compris

MyHealthTeams today introduced an exclusive video Q&A with Dr. Georgine Lamvu to the more than 100,000 U.S. members of MyEndometriosisTeam, the largest social network for women diagnosed with endometriosis.

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a proprietary technology to produce fully human polyclonal antibodies without the need for human plasma donors, today announced it has closed its Series B funding round at $14 million. New investor, global healthcare leader Merck, known as MSD outside the United States and Canada, was joined by South Dakota Equity Partners and several other foll

Arena Pharmaceuticals, Inc. announced that on July 15, 2020, the Compensation Committee of its Board of Directors granted to six new employees inducement stock options to purchase an aggregate of 35,850 shares of its common stock and 6,310 inducement restricted stock units.